FI875097A0 - OMAETTADE FOSFONSYROR SAMT DERAS DERIVAT. - Google Patents
OMAETTADE FOSFONSYROR SAMT DERAS DERIVAT.Info
- Publication number
- FI875097A0 FI875097A0 FI875097A FI875097A FI875097A0 FI 875097 A0 FI875097 A0 FI 875097A0 FI 875097 A FI875097 A FI 875097A FI 875097 A FI875097 A FI 875097A FI 875097 A0 FI875097 A0 FI 875097A0
- Authority
- FI
- Finland
- Prior art keywords
- carbon
- omaettade
- fosfonsyror
- carboxyl
- compounds
- Prior art date
Links
- 101100148710 Clarkia breweri SAMT gene Proteins 0.000 title 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 125000002837 carbocyclic group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphonic acid group Chemical group P(O)(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/60—Quinoline or hydrogenated quinoline ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Quinoline Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Dental Preparations (AREA)
Abstract
Compounds of the formula I <IMAGE> in which one or both of the acidic hydroxyl groups of the phosphonic acid part can be etherified, m is one or zero, R<1> denotes carboxyl, esterified carboxyl or amidated carboxyl, the heterocyclic five- or six-membered ring can additionally be substituted on the carbon and/or nitrogen, can have a carbon-carbon double bond or can be condensed with a carbocyclic 6-membered ring, starting from adjacent carbon atoms, A represents lower alkenylene; and salts thereof. These compounds are suitable as antagonists of the N-methyl-D-aspartate- sensitive amino acid stimulant receptor in mammals.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93370286A | 1986-11-21 | 1986-11-21 | |
| US93370286 | 1986-11-21 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI875097A0 true FI875097A0 (en) | 1987-11-18 |
| FI875097A FI875097A (en) | 1988-05-22 |
| FI86638B FI86638B (en) | 1992-06-15 |
| FI86638C FI86638C (en) | 1992-09-25 |
Family
ID=25464377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI875097A FI86638C (en) | 1986-11-21 | 1987-11-18 | FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT EFFEKTIVA OMAETTADE FOSFONSYROR. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0275820B1 (en) |
| JP (1) | JPH0686470B2 (en) |
| KR (1) | KR880006195A (en) |
| AT (1) | ATE60776T1 (en) |
| AU (1) | AU610841B2 (en) |
| CA (1) | CA1312608C (en) |
| DD (1) | DD273837A5 (en) |
| DE (1) | DE3768000D1 (en) |
| DK (1) | DK609487A (en) |
| ES (1) | ES2031927T3 (en) |
| FI (1) | FI86638C (en) |
| GR (1) | GR3001443T3 (en) |
| HU (1) | HU199857B (en) |
| IE (1) | IE60534B1 (en) |
| IL (1) | IL84492A0 (en) |
| MX (1) | MX9437A (en) |
| NO (1) | NO170853C (en) |
| NZ (1) | NZ222607A (en) |
| PH (1) | PH25465A (en) |
| PT (1) | PT86168B (en) |
| ZA (1) | ZA878699B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4968678A (en) * | 1988-02-19 | 1990-11-06 | Eli Lilly And Company | Tetrazole excitatory amino acid receptor antagonists |
| CA2000901A1 (en) * | 1988-10-21 | 1990-04-21 | Alexis A. Cordi | Phosphono-hydroisoquinoline compounds useful in reducing neurotoxic injury |
| US4902695A (en) * | 1989-02-13 | 1990-02-20 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| EP0424179A3 (en) * | 1989-10-20 | 1991-12-27 | John William Olney | Use of combined excitatory amino acid and cholinergic antagonists to prevent neurological deterioration |
| US5238958A (en) * | 1990-02-26 | 1993-08-24 | Warner-Lambert Company | Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals |
| US5194430A (en) * | 1990-05-17 | 1993-03-16 | Merrell Dow Pharmaceuticals Inc. | Heterocyclic-nmda antagonists |
| SE9003652D0 (en) * | 1990-11-15 | 1990-11-15 | Astra Ab | NEW HETEROCYCLIC COMPOUNDS |
| US5260286A (en) * | 1992-10-16 | 1993-11-09 | Japan Tobacco, Inc. | 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists |
| NZ501714A (en) | 1997-06-12 | 2001-09-28 | Rhone Poulenc Rorer Ltd | Imidazolyl-cyclic acetal derivatives, resins and intermediates thereof and use as TNF inhibitors |
| EP3427729A1 (en) | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid for use in treating epileptic diseases, disorders or conditions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2104079B (en) * | 1981-08-14 | 1985-08-21 | London Polytech | New aminoacid isomers, their production and their medicinal use |
| PH23848A (en) * | 1985-05-24 | 1989-11-23 | Ciba Geigy Ag | Certain phosphonic acids and derivatives |
-
1987
- 1987-11-16 ES ES198787810662T patent/ES2031927T3/en not_active Expired - Lifetime
- 1987-11-16 AT AT87810662T patent/ATE60776T1/en active
- 1987-11-16 DE DE8787810662T patent/DE3768000D1/en not_active Expired - Lifetime
- 1987-11-16 EP EP87810662A patent/EP0275820B1/en not_active Expired - Lifetime
- 1987-11-16 IL IL84492A patent/IL84492A0/en unknown
- 1987-11-18 PH PH36083A patent/PH25465A/en unknown
- 1987-11-18 FI FI875097A patent/FI86638C/en not_active IP Right Cessation
- 1987-11-19 CA CA000552204A patent/CA1312608C/en not_active Expired - Fee Related
- 1987-11-19 DD DD87309215A patent/DD273837A5/en not_active IP Right Cessation
- 1987-11-19 NZ NZ222607A patent/NZ222607A/en unknown
- 1987-11-19 PT PT86168A patent/PT86168B/en not_active IP Right Cessation
- 1987-11-20 DK DK609487A patent/DK609487A/en not_active Application Discontinuation
- 1987-11-20 IE IE314987A patent/IE60534B1/en not_active IP Right Cessation
- 1987-11-20 JP JP62292195A patent/JPH0686470B2/en not_active Expired - Lifetime
- 1987-11-20 ZA ZA878699A patent/ZA878699B/en unknown
- 1987-11-20 NO NO874854A patent/NO170853C/en unknown
- 1987-11-20 HU HU875161A patent/HU199857B/en not_active IP Right Cessation
- 1987-11-20 KR KR870013064A patent/KR880006195A/en not_active Application Discontinuation
- 1987-11-20 AU AU81455/87A patent/AU610841B2/en not_active Ceased
- 1987-11-23 MX MX943787A patent/MX9437A/en unknown
-
1991
- 1991-02-07 GR GR90401113T patent/GR3001443T3/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR880006195A (en) | 1988-07-22 |
| GR3001443T3 (en) | 1992-09-25 |
| PH25465A (en) | 1991-07-01 |
| MX9437A (en) | 1994-01-31 |
| JPH01135791A (en) | 1989-05-29 |
| FI86638C (en) | 1992-09-25 |
| EP0275820A2 (en) | 1988-07-27 |
| AU610841B2 (en) | 1991-05-30 |
| PT86168B (en) | 1990-08-31 |
| ZA878699B (en) | 1988-05-23 |
| NO170853B (en) | 1992-09-07 |
| HU199857B (en) | 1990-03-28 |
| IE873149L (en) | 1988-05-21 |
| PT86168A (en) | 1987-12-01 |
| NO874854L (en) | 1988-05-24 |
| NZ222607A (en) | 1990-10-26 |
| IE60534B1 (en) | 1994-07-27 |
| ATE60776T1 (en) | 1991-02-15 |
| NO170853C (en) | 1992-12-16 |
| ES2031927T3 (en) | 1993-01-01 |
| AU8145587A (en) | 1988-05-26 |
| DK609487D0 (en) | 1987-11-20 |
| EP0275820B1 (en) | 1991-02-06 |
| DE3768000D1 (en) | 1991-03-14 |
| FI875097A (en) | 1988-05-22 |
| NO874854D0 (en) | 1987-11-20 |
| HUT46331A (en) | 1988-10-28 |
| EP0275820A3 (en) | 1988-08-03 |
| FI86638B (en) | 1992-06-15 |
| CA1312608C (en) | 1993-01-12 |
| JPH0686470B2 (en) | 1994-11-02 |
| IL84492A0 (en) | 1988-04-29 |
| DD273837A5 (en) | 1989-11-29 |
| DK609487A (en) | 1988-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI862093A0 (en) | FOSFONSYROR OCH DERAS DERIVAT. | |
| FI875097A (en) | OMAETTADE FOSFONSYROR SAMT DERAS DERIVAT. | |
| NO873520L (en) | CHEMILUMINIZING ACRIDINE DERIVATIVES AND THEIR USE IN LUMINISENSIMMUNO ANALYSIS. | |
| ES2000368A6 (en) | Substituted-di-t-butylphenols. | |
| FI881892A0 (en) | Process for the preparation of new therapeutically useful 1,2,5,6-tetrahydropyridine derivatives | |
| SE8200570L (en) | TIAZOLIDE INGREDIENTS WITH PHARMACOLOGICAL ACTIVITY AND PROCEDURE FOR PREPARING THEREOF | |
| ES2053865T3 (en) | USE OF 2-SUBSTITUTED ETHANOSULPHONIC COMPOUNDS AS AUXILIARY GALVANOTECHNICAL PRODUCTS. | |
| ES2053868T3 (en) | 3-AMINOSIDNONIMINAS SUBSTITUTED, PROCEDURES FOR ITS OBTAINING AND ITS EMPLOYMENT. | |
| ES2000369A6 (en) | Substituted DI-t-butylphenols. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| PC | Transfer of assignment of patent |
Owner name: NOVARTIS AG |
|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: NOVARTIS AG |